We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.13B
AUM Growth
+$334M
Cap. Flow
-$281M
Cap. Flow %
-3.08%
Top 10 Hldgs %
21.52%
Holding
2,368
New
73
Increased
154
Reduced
1,152
Closed
75

Sector Composition

Rank Sector Weight
1 Technology 22.17%
2 Healthcare 13.84%
3 Financials 12.41%
4 Consumer Discretionary 11.36%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABR icon
1326
Arbor Realty Trust
ABR
$981M
$541K 0.01%
47,196
OSIS icon
1327
OSI Systems
OSIS
$3.77B
$541K 0.01%
6,973
-1,258
-15% -$93.9K
CFFN icon
1328
Capitol Federal Financial
CFFN
$1.09B
$541K 0.01%
58,388
ADEA icon
1329
Adeia
ADEA
$3.16B
$539K 0.01%
177,460
PRK icon
1330
Park National Corp
PRK
$3.75B
$539K 0.01%
6,577
THRM icon
1331
Gentherm
THRM
$1.32B
$538K 0.01%
13,143
-2,031
-13% -$84.9K
UAA icon
1332
Under Armour
UAA
$2.3B
$537K 0.01%
47,800
-1,486
-3% -$15.6K
HCAT icon
1333
Health Catalyst
HCAT
$132M
$536K 0.01%
14,644
SYKE
1334
DELISTED
SYKES Enterprises Inc
SYKE
$536K 0.01%
15,654
-2,667
-15% -$82.5K
KRTX
1335
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$535K 0.01%
6,914
CALM icon
1336
Cal-Maine
CALM
$3.87B
$533K 0.01%
13,890
CORE
1337
DELISTED
Core Mark Holding Co., Inc.
CORE
$531K 0.01%
18,358
-3,310
-15% -$96.7K
OPK icon
1338
Opko Health
OPK
$1.04B
$531K 0.01%
143,836
-28,161
-16% -$119K
ARI
1339
Apollo Commercial Real Estate
ARI
$886M
$528K 0.01%
58,624
-9,278
-14% -$85.4K
IMVT icon
1340
Immunovant
IMVT
$8.64B
$528K 0.01%
15,007
+5,560
+59% +$167K
REZI icon
1341
Resideo Technologies
REZI
$3.1B
$527K 0.01%
47,918
-7,339
-13% -$93K
ROIC
1342
DELISTED
Retail Opportunity Investments Corp.
ROIC
$527K 0.01%
50,605
CAKE icon
1343
Cheesecake Factory
CAKE
$5.57B
$524K 0.01%
18,905
FFBC icon
1344
First Financial Bancorp
FFBC
$3.6B
$524K 0.01%
43,646
MODN
1345
DELISTED
MODEL N, INC.
MODN
$524K 0.01%
14,843
DRNA
1346
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$522K 0.01%
29,035
SMCI icon
1347
Super Micro Computer
SMCI
$25.3B
$522K 0.01%
197,680
NPO icon
1348
Enpro
NPO
$7.12B
$522K 0.01%
9,247
CHRS icon
1349
Coherus Oncology
CHRS
$176M
$521K 0.01%
28,406
VRE
1350
DELISTED
Veris Residential
VRE
$519K 0.01%
41,089
-53,801
-57% -$735K

Similar funds

MetLife Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, MetLife Investment Management held 2,368 positions worth $9.13B, up 3.8% from $8.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $281M in Q3 2020, closing 75 positions and reducing 1,152 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $7.44M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Jazz Pharmaceuticals worth $4.53M.

  • MetLife Investment Management's largest Q3 2020 buy was Jazz Pharmaceuticals: 31,753 shares worth $4.53M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $34.6M increase.
  • MetLife Investment Management's biggest Q3 2020 reduction was Apple, cutting an estimated $22.2M.
  • MetLife Investment Management fully exited Slack Technologies, Inc. in Q3 2020, selling an estimated $7.44M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $9.13B portfolio in Q3 2020.
  • MetLife Investment Management opened 73 new positions and closed 75 in Q3 2020.
  • MetLife Investment Management's portfolio value rose 3.8% quarter-over-quarter to $9.13B.

Based on MetLife Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.